作者: Hilja Ruegg , Suzanne Watson , Melissa DelBello , Caleb Adler , L. Rodrigo Patino Duran
DOI: 10.1007/S40501-018-0160-2
关键词:
摘要: Bipolar disorder is a chronic mental illness that has significant morbidity and mortality implications globally. Increasingly, as with many health disorders, patients are being identified in primary care settings. In this overview, we discuss screening case identification, making the for judicious use of tools coupled follow-up clarifying questions. We review main modalities treatment including pharmacother-apy evidence non-pharmacotherapy adjunctive approaches. recommendations cautions regarding antidepressants population. Finally, explore role new models pharmacogenetic testing. As providers play critical bipolar there number important considerations both identification well initiating monitoring treatment.